Seer Places Survival Now at Least At 45 Percent, Could Be As High As 50 Percent For 1973-79 Patients
In Brief: DRCA Board Split On Guidelines For CCOP Remains Unresolved; Chop Implementation Talks Starting
OMB Orders NCI to Cut 12 Percent Until Final budget Is Approved; Grants Being Renegotiated
Local University Competing for Part FCRF Contract
Nutrition, Disease Oriented Contracts
Should Be Cut First, DCT Board Says
NTP Board Gives Concept Approvals
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
